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Abstract 
Cellular compartments and organelles organize biological matter. Most well-known organelles are 
separated by a membrane boundary from their surrounding milieu. There also are many so-called 
membraneless organelles and recent studies suggest that these organelles, which are supramolecular 
assemblies of proteins and RNA molecules, form via protein phase separation. Recent discoveries have 
shed light on the molecular properties, formation, regulation and function of membraneless 
organelles. A combination of techniques from cell biology, biophysics, physical chemistry, structural 
biology and bioinformatics are starting to help establish the molecular principles of an emerging field, 
thus paving the way for exciting discoveries, including novel therapeutic approaches for the treatment 
of age-related disorders. 
 
Introduction 
Eukaryotic cells are composed of numerous compartments or organelles. These organelles carry out 
specific functions and provide spatiotemporal control over cellular materials, metabolic processes, and 
signaling pathways. For example, the nucleus physically separates transcription from translation; this 
has allowed eukaryotes to develop a complex system of posttranscriptional control, which is largely 
absent from prokaryotes [1]. Other examples of membrane-bound organelles include lysosomes, the 
endoplasmic reticulum, and synaptic vesicles. However, cells also harbor organelles that lack a 
delimiting membrane. These are supramolecular assemblies composed of proteins, nucleic acids, and 
other molecular components. They are present in the nucleus (e.g., nucleolus, nuclear speckles), as 
well as in the cytoplasm (e.g., stress granules, processing bodies, the centriole) [2, 3]. Many of these 
cellular bodies were identified decades ago and numerous structural insights became available as the 
bodies were discovered. However, questions have remained about how these bodies form, why they 
form, and how their physical features contribute to biological function. These questions are starting to 
be answered, and recent advances in inter-disciplinary approaches have fueled the emergence of 
insights into their organization, molecular properties and regulation [2-4]. A growing understanding of 
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the underlying molecular principles and the physicochemical forces that drive the formation of 
membraneless organelles has enabled the elucidation of their diverse functions in a variety of cellular 
functions, including the stress response, the regulation of gene expression and the control of signal 
transduction [5-8]. In the past few years, there has been increasing evidence for the involvement of 
membraneless organelles in age-related disorders, such as amyotrophic lateral sclerosis [9-16]. 
Together, these discoveries have created a new field in cell biology focused on understanding how 
organization of cellular matter into membraneless organelles contributes to function, and how their 
dysregulation leads to disease.  
 
In this review, we examine the current state of the growing interest in membraneless organelles, 
providing insights into their biogenesis, organization, dynamics, regulation and function. We also 
discuss how recent findings can give us molecular insights in age-related diseases. This could pave the 
way for developing novel therapeutic strategies that leverage our understanding of phase separation. 
Finally, we highlight the major challenges that lie ahead and questions that need to be answered 
quantitatively and completely in the coming years.  
 
Membraneless organelles are formed via phase separation 
Many membraneless cytoplasmic and nuclear compartments (e.g., P bodies, stress granules, the 
Balbiani body, germ granules, PML bodies, Cajal Bodies, nuclear speckles, and the nucleolus) have been 
studied for a long time. However, the forces driving their formation mostly remained enigmatic. 
Several early studies highlighted the dynamic nature of these assemblies [17-19]. In 2005 it was argued 
that Cajal bodies behave as “semifluid spheres suspended in semifluid nucleoplasm” [17]. However, 
definitive experimental evidence for the physical nature of these assemblies was lacking. This changed 
in 2009, when Brangwynne, Jülicher and Hyman showed that P granules—RNA and protein-containing 
bodies in embryos of C. elegans—have liquid-like properties and form by phase separation [20]. This is 
a physical process that occurs when a supersaturated solution of components spontaneously separates 
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into two phases, a dense phase and a dilute phase that then stably co-exist. The proposed liquid-like 
nature of P granules was evident from their round appearance (the result of minimizing surface 
tension), deformability (fusion and fission events), and dynamic exchange of components. Similar 
observations were made two years later for nucleoli [21]. The liquids themselves are not “simple 
liquids”, which is a term that has specific connotations. A “simple liquid”, also known as a van der Waals 
fluid, comprises of spherical particles that interact via isotropic short-range potentials. Protein and RNA 
liquids are not spherical particles of uniform stickiness. Instead, they are best described as associative 
polymers and the liquids formed by such systems have distinctive structures that are defined by 
physical crosslinks that give rise to a panoply of material properties, including the possibility of spatially 
organized droplets where one polymer wets another [17, 22-27]. 
Phase separation is a well-known phenomenon in polymer chemistry [28]. However, its application to 
biomacromolecules is a much more recent development. Some proteins, such as hemoglobin, had 
previously been reported to undergo phase separation at high concentration in vitro [29, 30], but the 
significance of these observations remained unclear. Especially among crystallographers, liquid-liquid 
phase separation is frequently observed during crystallization trials [31]. Liquid droplet formation 
lowers the free energy of nucleation and thus is often a desired phenomenon in crystallization 
experiments [32]. However, the realization that phase separation might be the operational principle 
governing the formation of membraneless organelles to regulate biological functions and activities has 
emerged only recently. Strong support for this idea was provided by Rosen and colleagues in 2012. 
They showed that protein and RNA-containing bodies could be reconstituted from purified 
components; they further provided evidence that these reconstituted liquid bodies can promote the 
nucleation of actin polymers [6]. In the years following these seminal discoveries, there has been 
growing appreciation that  proteins and other macromolecules such as RNAs can form condensates 
that are either well-mixed or spatially organized, and switch between different material states [14, 16, 
33]. Membraneless organelles are known more generally as biomolecular condensates, and the 
constituent biomolecules obey the same physical principles as other polymers (Box 1). Accumulating 
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data underscores the variety of different phase transitions, and the complex molecular and physical 
interactions behind these processes. 
 
Molecular determinants of protein phase separation in vitro and in cells 
Proteomic and genetic studies have identified protein components of several membraneless 
organelles [23, 34-36]. These studies suggest that multivalency of adhesive domains and/or linear 
motifs is a defining feature of proteins (and perhaps RNA molecules) that drive phase transitions. 
Multivalency can come about in at least one of three ways: (1) Folded proteins, with well-defined 
interaction surfaces, can form oligomers that engender multivalency of other associative patches, 
which participate in stereospecific interactions; (2) Folded domains can be strung together by flexible 
linkers to generate linear multivalent proteins; (3) Intrinsically disordered regions can serve as scaffolds 
for multiple, distinctive short linear motifs. Of course, multivalency can also emerge by combinatorial 
arrangements of the three archetypes mentioned here or through emergent processes such as a 
structure formation within disordered regions. One feature that has attracted considerable attention 
is the presence of intrinsically disordered regions in proteins that drive phase transitions. These regions 
display a sequence-intrinsic preference for conformational heterogeneity (i.e., disorder) and are 
known as intrinsically disordered proteins/regions (IDPs/IDRs) [37]. Many IDRs have a biased amino 
acid composition and may be repetitive in sequence, hence, specific subsets of these IDRs are also 
referred to as low-complexity domains (LCDs) [23, 37-39]. The formation of supramolecular assemblies 
enriched in IDRs/LCDs leads to membraneless organelles with a variety of different properties (Figure 
1A-C). As one key example, distinct intermolecular interactions among IDRs, folded domains and 
nucleic acids gives rise to a range of assembly dynamics (Box 1). For example, the Balbiani body in 
oocytes is a solid-like protein assembly held together by strong β-sheet interactions [36]. In contrast, 
many RNA-protein (RNP) granules are dynamic and liquid-like, and genetic experiments have 
demonstrated that IDRs can aid in their assembly [40-42]. RBPs are known to have a multivalent 
modular domain architecture [43], which seems to be a critical factor in phase separation (Box 2). 
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Engineered proteins containing multiple interaction domains connected by flexible linkers exhibit 
spontaneous liquid-liquid demixing upon interacting with their specific targets [6]. These data suggest 
that so-called “fuzzy” interaction modes might enable a multitude of combinations amongst 
multivalent interaction domains and that this could be a general driver of protein phase transitions 
[44] (Box 3).  
 
In addition to serving as merely linkers, IDRs may also mediate ‘sticky’ interactions to promote phase 
transition [45]. McKnight and coworkers found that concentrated solutions of different IDRs could over 
time spontaneously form hydrogels [39], similar to existing observations made regarding FG-repeat 
containing nuclear pore proteins [46]. Shortly thereafter, Taylor and coworkers discovered disease 
mutations in the IDRs of hnRNPA1 and hnRNPA2B1 that resulted in accelerated assembly into higher 
order structures in vitro. Furthermore, these mutants promoted the spontaneous formation of stress 
granules with dramatically reduced dynamics in living cells [33]. Subsequent work from several groups 
showed that the proteins containing disease-associated IDRs such as hnRNPA1 or Fused in Sarcoma 
(FUS) can also make liquid droplets [10, 14, 16, 47-49]. These findings drew the attention of the entire 
field to the importance and functionality of IDRs in phase separation and provided an additional 
rationale for the abundance of protein disorder in eukaryotic proteins. 
 
How exactly are multivalent interactions encoded in IDRs? These sequences are often enriched in 
uncharged polar side chains (glutamine, asparagine, glycine, serine, proline), charged amino acids 
(arginine, lysine, glutamic acid, aspartic acid) or aromatic residues (phenylalanine and tyrosine). 
Interestingly, these residues do not seem to be distributed randomly throughout the sequence, but 
are often found as short linear interaction motifs (SLiMs), alternating charge blocks, or degenerate 
repeats [50, 51]. The range of sequence biases associated with IDRs that mediate phase separation 
indicates that there may be a range of underlying driving forces. These likely include electrostatic, 
dipole-dipole, pi-pi, cation-pi, hydrophobic, and hydrogen bonding interactions [9, 49, 50, 52-56] 
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(Figure 2A-B). Indeed, mutational studies have demonstrated that phase separation of different LCDs 
can be prevented by interfering with a variety of residue types [9, 10, 14, 16, 57]. Additionally, 
disrupting alternating charge blocks [49, 53] and mutating key residues in degenerate repeats [39, 46] 
can also perturb phase separation. 
 
Membraneless organelles frequently contain nucleic acids, especially RNA. Moreover, the proteins 
associated with membraneless organelles often possess RNA-binding domains or motifs [9, 23] and 
RNA promotes phase separation of various RNA-binding proteins [9, 10, 14, 16, 58-60] (Figure 2C). 
Interestingly, high RNA/protein stoichiometries can inhibit phase separation as well [10, 61]. RNA also 
regulates the nucleation and spatiotemporal distribution of membrane-less organelles [62, 63]. Even 
G-bodies, which are composed of proteins involved in glucose metabolism, require RNA for biogenesis 
[64]. RNA can also affect the material properties of protein droplets [48, 60]. Interestingly, repetitive 
RNA species have recently been found to phase separate through intermolecular base-pairing 
interactions, once more highlighting the universality of multivalency and structural polymorphisms as 
drivers of phase separation [65].  
 
Material states of membraneless organelles: liquids, hydrogels and aggregates 
Although several proteins have been shown to phase separate in the test tube, the underlying 
molecular structures associated with these phase separated states in vitro or in cells remain heavily 
debated. The Balbiani body is dependent on stable amyloid-like interactions [36], while the 
pericentriolar material and post-synaptic density are mediated by interactions amongst proteins that 
form coiled-coils [66, 67]. The picture is less clear for other assemblies. A lot of attention has been 
dedicated to better understand the internal structure of stress granules (SGs). SGs form reversibly 
when cells are stressed and it is thought that the formation of SGs is a form of stress response [62]. 
Recent work from the Parker lab suggests that the situation in cells might be more complicated than 
expected based on test tube experiments alone. It was shown that SGs contain stable cores that 
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withstand dilution, indicating their non-liquid character. Although, this does not rule out a combination 
of spontaneous phase separation and gelation as the route to forming SGs, the data suggest that 
dissolution of SGs might be a driven process to force the material out of kinetic traps [7, 23] (Figure 
1D). Indeed, super-resolution microscopy and cross-linking experiments have confirmed that SGs 
contain a labile liquid shell. These results point to a complex internal organization of SGs, a picture 
that, given recent work, is likely true for other membraneless organelles as well [24, 25, 68]. 
 
Missense mutations in several SG proteins cause neurodegenerative disorders such as amyotrophic 
lateral sclerosis (ALS), and both mutant and wildtype proteins are found aggregated in neurons [69-
72]. While stress granules are dynamic assemblies, these aggregates may have a fibrillar architecture 
[73, 74]. FUS and hnRNPA1 are such SG proteins with long low complexity IDRs that are mutated in ALS 
patients [75, 76]. Initial studies from McKnight and coworkers found that these disordered domains 
can form reversible hydrogels, and this is dependent on labile kinked beta sheets [39, 77]. Interestingly, 
repeated cycles of gelling/dissolution of hydrogels promoted a transition toward irreversible gels [14, 
15]. A different mechanism is suggested by studies of liquid droplets formed by full-length FUS and 
hnRNPA1, or their LCDs [14, 16]. In such liquid droplets, the LCDs seem to retain their tendency to be 
disordered, which is similar to their monomeric state [10, 56]. However, for many droplets formed by 
low complexity IDRs, especially in the case of constructs that contain the full-length protein, an 
eventual maturation into fibrillar solid aggregates occurs. Interestingly, the rate of maturation is 
enhanced by ALS-causing mutations [14, 16] (Figure 2C). Both the labile-to-stable gel [15] and liquid-
to-solid [14, 16] transitions could explain the pathological conversion of SGs to aggregates in ALS [78], 
but their exact relation to both cellular SGs and aggregates remains undetermined. 
 
How is specificity generated and maintained? 
Interestingly, many proteins reside in multiple distinct membraneless organelles [9, 23, 79]. As these 
proteins are significantly enriched in multivalent proteins, the question inevitably arises as to what 
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determines the specificity and ensures the integrity of these assemblies: How is fusion of distinct 
membrane-less organelles prevented? How are distinct sub-compartments within membraneless 
organelles maintained (e.g., in the nucleolus, Figure 1D)? How can a multiphase system such as the 
nucleolus be assembled and controlled? Recent work has suggested that differences in surface tension 
of protein droplets could mediate the formation of such multiphase droplets [24]. The key components 
of two sub-nucleolar compartments can phase separate independently, but the resulting droplets have 
different surface tensions. When mixed together, these droplets do not fuse but arrange in a droplet-
within-a-droplet topology, which appears strikingly similar to the nucleolus. This example hints at a 
more general principle that could underlie multiphase behavior in other membraneless organelles. 
 
Besides physical properties, specificity of granule assembly may derive from the specificity of direct 
protein-protein interactions. IDPs and proteins undergoing phase separation are enriched in SLiMs and 
degenerate repeats, which can serve as primary protein binding modules [51] (Figure 2A-B). Specificity 
may be related to additional features of IDPs, such as the number and spacing of repetitive binding 
motifs (multivalency), their post-translational modifications (PTMs), or the dynamics of the intervening 
linkers [44, 80]. Nonspecific electrostatic interactions, especially with RNA, could be critical to nucleate 
droplet assembly, and different IDRs respond differently to changing ionic strength [10, 49]. Although 
SLiMs possess some degree of specificity, the multiplicative effects of multiple SLiMs may determine 
the material properties and composition of a given assembly. 
 
Additionally, several key proteins in membraneless organelles possess folded dimerization or 
oligomerization domains. For example, G3BP1 contains a folded dimerization domain sufficient for SG 
targeting [81]. Other examples include components of PML and Cajal bodies, and nuclear speckles [82-
84]. TDP-43 can phase separate by dimerizing via a transient alpha helix in its LCD [11], and can 
multimerize through its folded N-terminal domain [85] (Figure 2B). This suggests that for some 
proteins, phase separation may occur via two distinct mechanisms that are physically coupled by the 
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protein structure. A convincing demonstration for such a mechanism of assembly has come from 
elegant work by the Brangwynne lab [86]. Shin et al. used a plant-derived light-inducible protein 
oligomerization domain to provide an optogenetic route for driving protein-protein interactions. 
Fusion of this oligomerization domain to LCDs known to drive phase separation yielded synthetic 
proteins that formed liquid droplets in cells upon light stimulation. These so-called ‘optodroplets’ 
indicate that the combination of specific oligomerization domains with LCDs indeed is a potent 
mechanism to mediate specific cellular phase transitions.  In addition to oligomerization domains, 
coiled-coils and β-zippers could provide the requisite multiplicative sticky interactions that are needed 
to drive the formation of membraneless organelles [39, 66, 67, 77] (Figure 2B). Interestingly, labile β-
zipper regions, as the ones driving FUS gelation, have recently been found to be enriched in numerous 
disordered proteins [87]. 
 
It has also become clear that there is a clear distinction between structural components of 
membraneless organelles, and client proteins, which only target the compartment [36, 66]. However, 
the exact molecular characteristics discriminating between both of these behaviors remain currently 
unknown. Preference of client proteins for certain assemblies could simply be mediated by the physical 
restrictions introduced by the constituent components of the compartment. The array of interactions 
in a protein droplet/gel creates a network with a specific mesh size. This mesh size could act as a 
diffusion barrier by allowing free diffusion of small molecules below the mesh size through the 
network, while limiting the entry of larger ones [49, 88, 89]. Additionally, membraneless organelles 
could be anchored in space, hereby preventing diffusion and fusion events. Aggresomes, for example, 
are perinuclear misfolded protein deposits kept in place by a cytoskeletal cage, which prevents their 
diffusion through the cell [90]. 
 
Spatiotemporal regulation 
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Given the rapidly expanding range of proteins that are being shown to undergo spontaneous phase 
separate in the test tube, it remains puzzling how cells can exercise precise control over this process. 
For example, several RBPs appear fully soluble at cellular concentrations well above their in vitro 
saturation concentration [14, 16], yet their transition to a different phase only occurs under specific 
conditions. Put simply, how is the cell able to avoid spontaneous and uncontrollable phase separation? 
This question is closely related to the above-mentioned ideas surrounding the origins of specificity of 
phase transitions.  
 
Work from different labs has shown that both serine- and tyrosine phosphorylation can control phase 
separation [12, 52, 91, 92], and the same holds true for arginine methylation [49, 93] and sumoylation 
[82]. Importantly, the activity of the dual specificity kinase DYRK3, which partitions into SG, was shown 
to be necessary for SG dissolution [94], suggesting that there might be specific cellular switches 
controlling these processes. Interestingly, proteins prone to phase separation, seem to be enriched in 
residues that are targeted by post-translational modifications (PTMs) [38]. Indeed, PTMs can 
dramatically alter the charge or other properties of these IDRs/LCDs, hence, modifying the sequence-
intrinsic driving forces to phase separate [49, 52] (Figure 2C).  
 
Another way for the cell to control phase transitions is by controlling the cellular concentrations and 
intracellular distribution, i.e., diffusivities of proteins that mediate phase separation (Figure 2C). The 
cellular concentrations of hnRNPA1 are higher than the in vitro saturation concentration, yet these 
molecules remain soluble in the nucleus for reasons that remain unclear [14]. Blocking nuclear import 
of hnRNPA1, which leads to its accumulation in the cytoplasm, leads to the spontaneous formation of 
SGs [14]. Interestingly, nuclear transport factors are themselves components of SGs, suggesting that 
nucleocytoplasmic transport processes might control phase separation in multiple, albeit unknown 
ways [79]. 
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Since RNA is involved in enabling the formation of multiple membraneless organelles, availability of 
specific RNA species may also regulate phase separation in time and space (Figure 2C). For example, 
expression of the non-coding NEAT-1 RNA is essential for paraspeckle formation [95]. Also, polysome 
disassembly upon cellular stress results in the cytoplasmic availability of free mRNA, which 
subsequently nucleates SGs. Inhibiting polysome disassembly prevents SG formation, even when the 
stress response is activated [18]. Moreover, the canonical stress-granule marker poly(A)-binding 
protein (PAB1) undergoes phase separation in response to heat stress, which leads to the release of its 
bound RNA [54]. This suggests a complex relationship between translational responses and SG 
formation. 
 
Disease, pathology and aging 
Several key proteins in neurodegenerative disorders are components of membraneless organelles. 
Hence, misregulation in the formation, maintenance or clearance of these assemblies may provide a 
stepping-stone for pathological aggregation [70, 71]. Indeed, spontaneous maturation of dynamic 
protein droplets and hydrogels to solid aggregates has been observed over the course of hours in the 
test tube and in cells [14-16, 24, 86]. This conversion indicates that the dynamic assemblies may be 
metastable or inherently unstable, and specific cellular processes keep them from solidifying (Figure 
2C). The fact that these liquid-to-solid transitions are accelerated by disease mutations, further 
highlights the significance of phase transition to pathology [11, 14-16].  These disease mutations seem 
to target β-zippers in IDRs, which makes them more prone to fold into stable amyloid structures [14, 
33, 96]. Yet, it is important to note that there is currently no direct evidence that pathological protein 
aggregates in patient brains result from solidification of SGs or other membraneless organelles. 
 
Disease mutations might also affect phase separation through the generation of aberrant protein and 
RNA species. Repeat expansion disorders prove especially interesting in this regard. Several of these 
disorders involve the formation of repeat RNA foci, which trap RBPs resulting in their loss-of-function 
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[97]. Interestingly, such repeat RNAs can themselves phase separate through multivalent base pairing, 
mimicking the foci observed in patients [65]. Additionally, several of these expanded repeat RNAs have 
been found to be translated, generating peptide repeats [98]. Translation of ALS-causing GGGGCC 
repeat expansions, for example, produces different dipeptide repeats [99-101]. Two of them, namely 
glycine-arginine and proline-arginine dipeptide repeats, localize to different membraneless organelles, 
including SGs [9, 12, 13, 57, 102]. SGs positive for these pathogenic peptides were less dynamic, and 
moreover, recruited aggregation-prone proteins such as TDP-43 [9, 13]. 
 
SGs require autophagy for clearance [103]. Interestingly, mutations in autophagy genes are the cause 
of various diseases, including ALS [104] and the efficacy of autophagy is also known to decrease with 
age [105]. Besides autophagy, chaperones are also involved in both maintaining SG fluidity and their 
clearance [106, 107]. These observations suggest that the inability of the cell to tightly control these 
assemblies may lead to pathological aggregation. Nuclear transport is also known to deteriorate with 
aging [108] and is being increasingly implicated in protein aggregation diseases [79, 109-114].  
 
Mitochondrial dysfunction is a cornerstone of aging and neurodegeneration [115], potentially causing 
a reduction in ATP levels that could affect the regulation of membraneless organelles. Numerous SG 
proteins contain ATPase domains, and lowering cellular ATP levels decreases the dynamic character of 
these organelles [23]. Additionally, there is evidence that cellular ATP can act as a chemical hydrotrope 
directly preventing phase separation and aggregation. This feature of ATP is independent of its role in 
providing energy for active cellular processes [116]. Hence, defects in mitochondrial respiration may 
promote protein aggregation in aging and disease, either through an overall reduction in cellular ATP 
levels, or by the impairment of ATP-dependent processes that maintain the liquidity of membraneless 
organelles. 
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Given the importance of PTMs in the regulation of phase separation, it is interesting to note that 
several pathological protein aggregates show specific PTM signatures. For example, Tau 
phosphorylation is a hallmark of pathology in Alzheimer’s disease [117], and interestingly, tau 
phosphorylation promotes aggregation and phase separation in vitro [118]. 
 
Although protein aggregation and phase transitions are mostly studied in the context of 
neurodegenerative disorders, they are implicated in a wide variety of pathological conditions, including 
viral infections and cancer. Several of the key proteins associated with neurodegeneration are also 
implicated in different types of cancer [119]. For example, the LCD of FUS, which is involved in SG 
targeting and aggregation in ALS, has been shown to undergo an oncogenic fusion events in 
liposarcomas [120]. Indeed, cancer-related fusion proteins are often enriched in disordered low 
complexity domains, indicating this may be a common mechanism [121, 122]. Indeed, the 
transcriptional activation potential of FUS LCD as well as its human homologs EWSR1 and TAF15, 
implicated together in a family of cancers, is highly correlated with their in vitro hydrogel binding 
capability and ability to recruit the C-terminal domain of Polymerase II to such hydrogels [92]. The 
mechanism through which FUS LCD and its homologs mediate transcriptional activation remains 
unclear, but is thought to involve phase separation [5, 10, 123, 124]. Additionally, increased SG and 
paraspeckle formation have been linked to a poor prognosis for cancer survival [125-127]. Lastly, 
aggregation of the tumor suppressor p53 resulting in its loss of function is a major mechanism in cancer 
[128], and compounds preventing its aggregation have been successful in preclinical animal models 
[129].  
 
SGs have also been implicated in the antiviral stress response [130] and viruses have evolved numerous 
ways of interfering with SG assembly. Moreover, some viruses, such as flaviviruses including Zika, even 
hijack SG proteins to aid in their replication [130, 131]. Although still in its infancy, we would argue that 
since protein aggregation and phase separation are implicated in numerous human pathological 
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conditions, a better understanding of these processes will help us develop novel therapeutic strategies 
in the wider field of human medicine. 
 
Road towards novel therapy? 
As outlined in the foregoing discussion, protein phase separation is suspected to be intimately linked 
to pathological protein aggregation and disease. The ultimate vindication of our understanding of its 
pathological importance would be a demonstrated ability to harness this information and devise new 
ways of treatment. Cellular phase transitions can be targeted by different chemicals interfering with 
hydrophobic [7, 57, 132] or polar [65] interactions. However, such general approaches would be 
expected to target a wide range of membraneless organelles in the cell [7, 57, 65] and may therefore 
be poorly situated as therapeutic options.  
 
Antisense oligonucleotides (ASOs) offer a likely suitable selective approach to specifically knockdown 
(KD) key players in these aberrant phase transitions. Although ASOs targeting pathological proteins 
were successful in different mouse models [133], their application is limited to non-essential proteins. 
In case of essential proteins, ASOs could target non-essential functional partners, which regulate phase 
transition. The feasibility of this approach was illustrated in the case of the essential protein TDP-43 in 
ALS models. Ataxin-2 was previously identified as an ALS disease modifier in animal models and in 
humans [134]. Subsequently, it has been shown that Ataxin-2 directly recruits TDP-43 to SGs, providing 
a putative mechanism for how it may promote TDP-43 aggregation [135]. Unlike TDP-43 KD, ataxin-2 
KD is well tolerated in mice. Compellingly, KD of ataxin-2 in an ALS mouse model reduced the number 
of TDP-43 aggregates in the spinal cord of the affected mice and dramatically extended survival [135]. 
Similarly, knockdown of stress granule protein Tia-1, which is known to interact with Tau, was also 
shown to prevent Tau pathology and toxicity in neuronal culture and rodent models [136, 137]. These 
observations convincingly demonstrate that targeting phase transitions through ASO technology could 
16 
 
be a viable strategy to halt pathological aggregation in TDP-43 and Tau proteinopathies, and possibly 
in other protein aggregation diseases. 
Lastly, given that protein aggregation and phase separation are tightly controlled by the cell’s protein 
degradation and chaperone machinery [103, 106, 107, 138], ongoing efforts are focused on finding 
drugs that upregulate these pathways [139] or on the generation of potent engineered disaggregases 
which could antagonize pathological phase transitions [140, 141]. Unraveling the complex regulation 
of protein phase separation will be key in identifying new pathways, which could be targeted to correct 
pathological phase transitions. 
 
Concluding remarks 
In recent years, it has become clear that numerous cellular organelles are formed through the process 
of phase separation. Although these organelles have been studied for decades (or in the case of the 
nucleolus over a century) their dynamic nature and its relevance to their formation, function, and 
physiopathology has only recently come to light. Leveraging prior insights from polymer chemistry has 
dramatically advanced our understanding of membraneless organelles in this rapidly progressing field 
of cell biology, and inspired new approaches to further explore their underlying biophysics. 
Compellingly, these recent findings are already opening novel avenues to target aberrant protein phase 
transitions in human disease. Additionally, understanding the relationship between sequence and the 
resulting material state may also lead to novel synthetic biomaterials [142, 143]. 
We must be fully aware, though, that we are far from completely understanding the complex biology 
behind membraneless organelles and their functional roles (Box 4). To this end, we have compiled a 
list of – in our opinion – the key outstanding questions that remain unanswered (see Outstanding 
Questions box). Addressing these questions will be of pivotal importance for gaining further insight 
into protein phase separation. Developing novel molecular biological and cell biological tools will be 
essential for this endeavor. At the moment, purification and high-resolution structural studies of 
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membraneless organelles present a bottleneck, especially in a cellular context. Only by generating 
tools that can specifically target individual granules we will be able to repurpose them for new disease 
treatments, and translate our basic biological knowledge to the bedside. Protein phase separation has 
not yet given us all its secrets, and an exciting future lies ahead of us. 
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Glossary 
Gel: Defined by a system- or droplet-spanning network formed by the constituent macromolecules. 
The crosslinks are either covalent bonds (chemical gel) or non-covalent bonds (physical gel). The 
material properties of gels vary in a broad range dictated by the lifetimes of crosslinks, the extents of 
crosslinking, and the crosslinking patterns. Associative polymers can form physical gels. Water-soluble 
polymers form hydrogels. 
Intrinsically disordered (ID) protein region: Protein regions that adopt multiple structures or exhibit a 
fast conformational exchange in their native state. 
Liquid: One of the four fundamental states of matter. Characterized by a definite volume, but no fixed 
shape. Liquids minimize their surface area (to reduce surface tension), which often leads to the 
formation of spherical droplets. If two droplets fuse, they also adopt a spherical shape. In liquids, local 
spatial ordering, i.e., preferred inter-molecular distances and orientations, does not exceed the 
dimensions of a few molecules, beyond which the molecules are randomly organized. This leads to fast 
reorganization of liquid structure, and also enables annexchange of components with the 
surroundings. 
Liquid crystal: A material state, which shares properties with both liquids and crystals. The constituent 
molecules are oriented in a crystal-like manner, yet can flow, similarly to liquids. Ordering is 
considerable on a molecule-scale, at least into one direction.  Liquid crystals frequently undergo phase 
transition in response to temperature changes.  
Liquid-liquid demixing: Two liquids co-exist as separate phases instead of a mixed solution (see phase 
separation). 
Low-complexity domain (LCD): A protein segment, which is enriched in or composed of only a few 
amino acids. These often follow simple patterns, like tandem repeats and are associated with fast 
evolutionary rates. 
Material state or phase: There are four material states or phases matter can occur in: gas, liquid, solid 
and plasma.  
Membraneless organelle: A non-membrane-bound cellular compartment. Membraneless organelles 
are usually composed of protein and nucleic acids assemblies and sample a broad range of material 
states. 
Phase separation: Phase separation reflexts a demixing transition, in which a homogenous and well 
mixed solution re-arranges itself such that distinct regions of space are occupied by a distinct 
concentration of species. In the simplest case of a binary mixture (polymer and solution), phase 
separation yeilds a high concentration region and a low concentration region. In Flory-Huggins solution 
theory, the free energy of mixing associated with a binary mixture includes a single interdispersing 
term (). If this term is favorable ( < 0), the components will form a homogenous well-mixed solution. 
If the interdispersing term is unfavorable ( > 0) demixing will occur and a two-phase solution will 
appear. 
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Phase transition: While phase separation refers to a demixing of an initial homogeneous solution, 
phase transition describes the switch in phase of a molecule, e.g. liquid to solid. 
Solid: Although both liquids and solids are termed as condensed matter, they differ in the range of 
long-range organization of their components and dynamics. Material states of membraneless 
organelles can also be crystalline, semi-crystalline, or liquid-crystalline depending on the extent of 
spatial ordering and the directional preferences for spatial ordering.  
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Outstanding Questions Box  
1. What are the exact biological functions of phase separation? Why did cells evolve 
membraneless organelles? What makes liquid/gel assemblies functionally different from 
canonical protein complexes? 
2. We have a basic understanding of the physical force(s) driving phase separation, yet deeper 
insights into the interactions at the atomic level will be pivotal in better understanding these 
phases. 
3. What are the essential and non-essential components of different membraneless organelles, 
and what are their sequence and structural properties? 
4. Despite a few examples, we know surprisingly little about how cells spatiotemporally regulate 
phase separation. This will be key in understanding how biology regulates physics. Which 
regulatory pathways are involved? 
5. A predictive framework on how specificity of membraneless organelle composition is 
generated is currently completely lacking. Which principles target proteins and RNAs to 
specific phases and what prevents the coalescence of distinct membraneless organelles?  
6. While progress is being made in determining the internal structure of test tube granules, we 
mostly lack the tools to pursue this question in living cells. How can we investigate the internal 
organization of membraneless organelles in living systems? 
7. What are the differences between physiological and pathological assemblies? Which factors 
drive this conversion in disease? 
8. How do disease mutations and aging specifically affect phase separation of membraneless 
organelle components? What are the associated molecular events? 
9. Why do diseases associated with protein aggregation display such profound cell type 
specificity? What makes (specific) neurons especially sensitive to perturbations in 
proteostasis? 
10. Can we harness our growing understanding of biological phase separation to develop novel 
therapeutic treatments options? Can we devise ways to specifically target membraneless 
organelles or interactions within them?  
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Trends Box  
1. Phase separation is known to play a role in a variety of cellular processes, including formation 
of classical membraneless organelles, signaling complexes, the cytoskeleton and numerous 
other supramolecular assemblies. 
 
2. The concept of phase separation provides a new framework for our understanding of the 
functional role of sequence degeneracy (low-complexity) and protein disorder. 
 
3. Accumulating evidence points to a key role for phase transitions in human diseases associated 
with protein aggregation, and to the misregulation of membraneless organelles in disease. 
 
4. Understanding the physical principles and molecular interactions behind protein phase 
separation could inspire novel biomaterials. 
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Box 1: Membraneless organelles can be liquids, solids or gels 
Membraneless organelles are often referred to as liquids, but this designation also creates 
considerable confusion because of the mental picture this might conjure. In this regard, it is worth 
noting that all liquids, even so-called simple liquids made up of hard spheres, have a well-defined 
structure that is quantifiable in terms of pair-correlation functions. These functions show that liquids 
adopt ordered arrangements, rather like crystalline solids, on length scales that are of the order of 
magnitude of the size of a typical molecule. On longer length scales, the molecules are randomly 
organized, in a manner that is reminiscent of dilute gases. Aspherical molecules have spatial as well as 
directional order as is the case with water and other molecular liquids, including polymeric ones. Local 
spatial ordering and preferred inter-molecular orientations arise from hierarchies of interactions with 
different spatial extents and directional preferences such as long-range electrostatics, multipolar 
interactions, hydrogen bonds, forces, and short-range interactions involving pi-systems.  
In the world of biological phase separation, gels are often thought of as being synonymous with solids, 
and gelation is thought to be the process of transitioning from a liquid to solid. Gels are generated by 
a system-spanning network of intermolecular interactions, along which one  can “walk” across a gel by 
relying on the connectivity of the constitutive macromolecules. If gels have long-lived crosslinks and a 
high density of crosslinks, then the material properties can be consistent with those of solids. In 
contrast, gels with short-lived crosslinks and/or a low-level of crosslinking will have material properties 
that are akin to those of liquids.  
In reality, an organelle can be a liquid, some form of solid, a liquid-gel, a solid-gel, a crystalline solid, a 
semi-crystalline solid or liquid-crystalline depending on the extent of spatial ordering and the 
directional preferences for spatial ordering. To assign an appropriate designation to a membraneless 
organelle, one would have to, at a minimum, measure five quantities, namely, (1) the concentrations 
of macromolecules within droplets to quantify density, (2) the extent of long-range spatial order of 
molecules with respect to one another to quantify the intermolecular organization within the droplet, 
(3) the extent of physical crosslinking amongst molecules, (4) the interfacial tension between the 
droplet and its surroundings, and (5) the timescales for making and breaking bonds within droplets.  
Ideally, all five measurements would be performed using in vitro facsimiles of droplets and within the 
appropriate body in living cells to uncover the commonalities and differences between the two 
scenarios.  
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Box 2 Insights from polymer theories and multiscale simulations  
Phase transitions are cooperative transitions that involve the collective effects of interacting modules 
from multivalent proteins. (1) They can undergo gelation, whereby they form physically crosslinked, 
system-spanning networks, where the crosslinks are non-covalent interactions among associative 
domains/motifs. (2) Protein polymers can also condense via a density transition enabling the formation 
of a dense phase that coexists with dilute phases. The physics of gelation, or more precisely sol-gel 
transitions, have been deployed to understand the impact of valence of associative domains/motifs on 
the driving forces for phase transitions [6, 144]. In contrast, the physics of density transitions explain 
the formation of condensed phases that are spherical in shape and display many properties that are 
congruent with those of liquids [20, 50]. In reality, the physical principles underlying both types of 
transitions synergistically underlie the formation of membraneless organelles, which are better known 
as biomolecular condensates. 
Multivalent proteins belong to a class of polymers known as associative polymers in that they can 
undergo gelation aided by phase separation or gelation without phase separation. Here, valence refers 
to the effective numbers of adhesive domains/motifs that provide specificity in intra- as well 
intermolecular interactions. Recent computer simulations and adaptations of the theories of 
associative polymers show that multivalent proteins may be parsed into associative domains/motifs, 
so-called stickers, interspersed by spacers [80]. The stickers enable physical crosslinking, whereas the 
spacers or linkers determine whether or not gelation will be driven by phase separation. Linkers or 
spacers that are preferentially solvated will inhibit phase separation, whereas linkers/spacers that 
prefer self-associations or are indifferent about whether they interact with themselves or solvent, will 
enable gelation via phase separation. The key result emerging from theory, simulations and recent 
experiments [89] is a clear role for intrinsically disordered regions as determinants of the nature of 
phase transitions as well as the densities and organization of protein modules within droplets.  
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Box 3: Heterogeneity matters for organelle dynamics 
Nuclear pore complexes possess high frequency, weakly interacting FG motifs in disordered regions, 
yet exhibit long recovery times in FRAP experiments [145]. What needs to be considered is that 
repetitive motifs or SLiMs may generate a variety of contact topologies, resulting in large number of 
iso-energetic microstates and higher entropy. This requires highly dynamic linkers (e.g., IDRs) to 
minimize the coupling between the binding sites and enable a multitude of arrangements.  In addition, 
weak-affinity or non-specific motifs may simultaneously interact with multiple target sites, or even 
with more binding partners via weak, short-range contacts. In contrast to the one-to-one binding 
model, cation-pi, pi-pi, aromatic hydrogen bonds and van der Waals interactions are realized at 
different extents with alternative target sites causing uncertainty in defining contacts between the 
multivalent motifs. Computer simulations using a mathematical framework show that partial, 
heterogeneous interactions can lower the phase boundary by an order of magnitude as compared to 
the one-to-one binding model [146]. From this aspect, the higher-order assembly resembles to an 
encounter complex, which facilitates productive contacts, yet enables fast reorganization of the 
interface. This also implies that heterogeneous systems can undergo phase transition at lower valency 
[146]. Different, redundant interaction patterns could be generated by large number of structural 
states [44]. Albeit surprising, conformational heterogeneity could also promote assembly via entropic 
effects, as was observed in the case of FUS [10]. Taken together, interaction and structural 
heterogeneity are likely the critical determinants of assembly and dynamics of membraneless 
organelles, and not mere multivalency of the constituent proteins. As such heterogeneity is ubiquitous 
to protein interactions [147], it is possible that the molecular driving forces associated with 
membraneless organelles are maybe not fundamentally different from traditional protein complexes 
and 'lower-order' assemblies [44].   
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Box 4: What is the function of membraneless organelles? 
Numerous proteins have seemingly evolved the ability to drive the formation of or be recruited to 
membraneless organelles. Yet why do cells need such compartments? What is their biochemical 
function? Surprisingly, these questions remain largely unanswered. 
Compartmentalization in different forms and scales is widely used by organisms. Our stomach is a well-
defined organ, which serves one main purpose, i.e., digesting food through acid hydrolysis. Obviously, 
such a chemical reaction is best carried out if the body has a means to concentrate both food and the 
acid into one singular compartment. Additionally, this compartmentalization protects other organs 
from exposure to acid. Similarly, our cells have evolved a strikingly similar mechanism. Lysosomes 
create an acidic compartment to degrade cellular waste. Through their membrane-barrier lysosomes 
can both concentrate the reaction components, and at the same time protect the rest of the cell from 
its harmful effects. Another example of organ-organelle parallels includes fat tissue and lipid droplets, 
which store energy under the form of lipids for later use. Additionally, bodies and cells can amplify 
signals from the environment by compartmentalizing signal reception: Our eyes focus incoming light 
onto our retina, which concentrates the light receptors. On the subcellular level, neurons also 
concentrate their receptors in distinct substructures, namely the synapses. 
From these analogies four main functions arise for compartmentalization, being (1) concentration of 
(bio)chemical reactions, (2) sequestering harmful components, (3) storage of biomolecules, and (4) 
signal amplification. Interestingly, all these functions exist in the realm of membraneless organelles. 
First, concentration of cytoskeleton components through phase separation promotes their nucleation 
into filaments [66, 148], and similarly splicing is controlled by multivalent assembly of splicing factors 
on mRNA [149]. Second, although protein aggregates in disease are considered harmful, accumulating 
evidence suggests that they could be an initial rescue mechanism of the cell to sequester the more 
toxic protein oligomers [150, 151]. Third, numerous assemblies function as storage granules, as they 
sequester proteins and other biomolecules under times of stress or quiescence for later reuse [64, 
152]. Fourth, by concentrating receptors and signaling molecules a cell can amplify certain signaling 
pathways. In light of this, different membrane receptors achieve exactly this through protein phase 
separation [6, 8].  
Although we have not fully unraveled the complex function of phase separation in the cell, these 
examples give us a glimpse into why cells could clearly benefit from the formation of membraneless 
organelles.   
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Figures 
 
Figure 1: Different flavors of protein phase transitions. (A) Material state and dynamics can vary in a 
wide range from liquid like to solid states. (B) Example of the protein FUS which can spand the entire 
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range of material states in vitro. Pictures adapted from reference [16]. (C) Examples of membraneless 
organelles and their reconstituted in vitro counterparts. Pictures adapted from references [48, 66, 72, 
89, 153] (D) Several membraneless organelles have complex toplogies with different subcompartments 
that may belong to different states. All scale bars 5µm unless indicated.  
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Figure 2:  Interactions and regulatory mechanisms implicated in protein phase separation. (A) 
Overview of different kinds of contacts, which have been observed in protein phase separation. (B) 
Examples of phase separating proteins illustrates importance of multivalency, highlighted by an array 
of interaction modules within a single protein. (C) Different mechanisms regulate the material state 
and nucleation of protein phase separation. 
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